Gene · 6383
Papers4,416
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,416
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications. | Biochimie | 2024 | 38640996 | PubTator, text mining | PubMed |
| Cellular and Transcriptional Response of Human Astrocytes to Hybrid Protein Materials. | ACS Appl Bio Mater | 2024 | 38632900 | PubTator, text mining | PubMed |
| Temporal Alterations in Cerebrovascular Glycocalyx and Cerebral Blood Flow after Exposure to a High-Intensity Blast in Rats. | Int J Mol Sci | 2024 | 38612392 | PubTator, text mining | PubMed |
| Cancer-associated point mutations within the extracellular domain of PTPRD affect protein stability and HSPG interaction. | FASEB J | 2024 | 38593345 | PubTator, text mining | PubMed |
| Population-based screening for colorectal cancer in Wuhan, China. | Front Oncol | 2024 | 38487726 | PubTator, text mining | PubMed |
| The signature of cancer methylation markers in maternal plasma: Factors influencing the development and application of cancer liquid biopsy assay. | Gene | 2024 | 38342253 | PubTator, text mining | PubMed |
| Everolimus exerts anticancer effects through inhibiting the interaction of matrix metalloproteinase-7 with syndecan-2 in colon cancer cells. | Am J Physiol Cell Physiol | 2024 | 38314724 | PubTator, text mining | PubMed |
| Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors. | J Lipid Atheroscler | 2024 | 38299167 | PubTator, text mining | PubMed |
| Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma. | World J Clin Oncol | 2024 | 38292662 | PubTator, text mining | PubMed |
| Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes. | Pharmaceutics | 2024 | 38276507 | PubTator, text mining | PubMed |
| Proteomic insights into mental health status: plasma markers in young adults. | Transl Psychiatry | 2024 | 38267423 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. | Mol Cancer | 2024 | 38254110 | PubTator, text mining | PubMed |
| Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications. | Curr Oncol | 2024 | 38248118 | PubTator, text mining | PubMed |
| Dating Skin Lesions of Forensic Interest by Immunohistochemistry and Immunofluorescence Techniques: A Scoping Literature Review. | Diagnostics (Basel) | 2024 | 38248045 | PubTator, text mining | PubMed |
| Glucocorticoid stress hormones stimulate vesicle-free Tau secretion and spreading in the brain. | Cell Death Dis | 2024 | 38238309 | PubTator, text mining | PubMed |
| Evaluating the clinical performance of SDC2/NDRG4 methylation for colorectal cancer detection. | Epigenomics | 2024 | 38226561 | PubTator, text mining | PubMed |
| Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis. | Clin Biochem | 2024 | 38224931 | PubTator, text mining | PubMed |
| Hippo cell signaling and HS-proteoglycans regulate tissue form and function, age-dependent maturation, extracellular matrix remodeling, and repair. | Am J Physiol Cell Physiol | 2024 | 38223931 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
| Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma. | Virol J | 2024 | 38216938 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6383/papers?page=11